Very First Real-World Data on Zongertinib Use in Non-Small Cell Lung Cancer Patients with Her2 Mutations: A Brief Report
Cancer treatment and research communications（2025）
Key words
zongertinib,BI 1810631,HER 2 mutation,HER 2 inhibitors,non-small cell lung cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined